News Updates

Company News

Industry Trends

National policy

03-06

Image name

Improve detection methods for mental disorders and reduce the room for improper practices.

Improve detection methods for mental disorders and reduce the room for improper practices.

06-21

Image name

Breaking News: The application submitted by our agency to convert the prescription drug “Yinhuang Containing Oral Drops” into an over-the-counter (OTC) drug has been approved and publicly announced by the National Medical Products Administration.

Breaking News: The application submitted by our agency to convert the prescription drug “Yinhuang Containing Oral Drops” into an over-the-counter (OTC) drug has been approved and publicly announced by the National Medical Products Administration.

12-17

Image name

Research on Traditional Chinese Medicine Formulations—As residents’ awareness of health and wellness continues to rise, the development trend of traditional Chinese medicine formulations remains promising.

Research on Traditional Chinese Medicine Formulations—As residents’ awareness of health and wellness continues to rise, the development trend of traditional Chinese medicine formulations remains promising.

12-17

Image name

The Pharmaceutical and Biotechnology Industry Embraces the Third Biopharmaceutical Revolution (Part 1): Part One—The Future Has Arrived, and Gene Therapy’s Foundations Are Firmly Established

The Pharmaceutical and Biotechnology Industry Embraces the Third Biopharmaceutical Revolution (Part 1): Part One—The Future Has Arrived, and Gene Therapy’s Foundations Are Firmly Established

12-17

Image name

In-depth Special Report on Innovative Pharmaceutical and Biologic Drugs (Part 1): ADCs—The Commercialization Wave of ADC Therapeutics Is Upon Us. We Focus on Three Core Investment Opportunities: Platform Value, New Breakthroughs in Treatment, and the Outsourcing Industry.

In-depth Special Report on Innovative Pharmaceutical and Biologic Drugs (Part 1): ADCs—The Commercialization Wave of ADC Therapeutics Is Upon Us. We Focus on Three Core Investment Opportunities: Platform Value, New Breakthroughs in Treatment, and the Outsourcing Industry.

12-17

Image name

The Pharmaceutical Industry Over the Past Decade, as Seen by Pharmaceutical Analysts

The Pharmaceutical Industry Over the Past Decade, as Seen by Pharmaceutical Analysts

12-17

Image name

Medical Insurance Negotiations—Disrupting the Transformation of the Innovative Drug Market

Medical Insurance Negotiations—Disrupting the Transformation of the Innovative Drug Market

12-17

Image name

Innovative Drugs in the Biopharmaceutical Industry: Innovative Oncology Drugs—Technological Upgrades and Generational Shifts, Intensifying Competition—20200924—China Merchants Bank—21 Pages

Innovative Drugs in the Biopharmaceutical Industry: Innovative Oncology Drugs—Technological Upgrades and Generational Shifts, Intensifying Competition—20200924—China Merchants Bank—21 Pages

12-17

Image name

Shao Wei – Practice and Reflection on “Internet Plus Healthcare” 2019

Shao Wei – Practice and Reflection on “Internet Plus Healthcare” 2019

12-17

Image name

Deep Report on the Retail Pharmacy Industry—Part 1: Two Key Drivers Remain Strong; Drawing Insights from Japan to Highlight Growth Potential of Leading Players

Deep Report on the Retail Pharmacy Industry—Part 1: Two Key Drivers Remain Strong; Drawing Insights from Japan to Highlight Growth Potential of Leading Players
< 12 >

Rico International (Beijing) Medicine Technology Co., Ltd.

Tel: +86-10-53329998

Address: Room 905A, Building B, East Zone, Jianwai SOHO, No. 39, Middle Section of East Third Ring Road, Chaoyang District, Beijing

Facebook Linkedin Twitter Tumblr Pinterest

©2026 Rico International (Beijing) Medicine Technology Co., Ltd.  Powered by：CEglobal

Business license